Treatment routines were closely supervised along with risk factors for heart disease, including weight, cholesterol levels, blood pressure, diabetes and smoking, according to the Science Daily.After five years, 97 percent of the patients had been treated with DMARDs, dropping both the chemical markers of inflammation and the physical appearance of their arthritis.